Evidence map›Paper›PMID 30075081›Full record

ReviewACS synthetic biology2018

Human Artificial Chromosome with Regulated Centromere: A Tool for Genome and Cancer Studies.

Natalay Kouprina, Nikolai Petrov, Oscar Molina, Mikhail Liskovykh, Elisa Pesenti, Jun-Ichirou Ohzeki, Hiroshi Masumoto, William C Earnshaw, Vladimir Larionov

Open access · hybridAbstract readReview
In one paragraph

Review in ACS synthetic biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The design and engineering of synthetic genomes.Nature reviews. Genetics · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Human AlphoidCells · 2020
    Article
  17. Review
  18. TAR Cloning: Perspectives for Functional Genomics, Biomedicine, and Biotechnology.Molecular therapy. Methods & clinical development · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Natalay KouprinaDevelopmental Therapeutics Branch , National Cancer Institute, NIH , Bethesda , Maryland 20892 , United States.ORCID 0000-0001-8690-5625
Nikolai PetrovDevelopmental Therapeutics Branch , National Cancer Institute, NIH , Bethesda , Maryland 20892 , United States.
Oscar MolinaJosep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona , Casanova 143 , 08036 Barcelona , Spain.ORCID 0000-0001-7585-4519
Mikhail LiskovykhDevelopmental Therapeutics Branch , National Cancer Institute, NIH , Bethesda , Maryland 20892 , United States.
Elisa PesentiWellcome Centre for Cell Biology , University of Edinburgh , Edinburgh EH9 3JR , Scotland.
Jun-Ichirou OhzekiLaboratory of Chromosome Engineering, Department of Frontier Research and Development , Kazusa DNA Research Institute , Kisarazu , Chiba 292-0818d Japan.
Hiroshi MasumotoLaboratory of Chromosome Engineering, Department of Frontier Research and Development , Kazusa DNA Research Institute , Kisarazu , Chiba 292-0818d Japan.
William C EarnshawWellcome Centre for Cell Biology , University of Edinburgh , Edinburgh EH9 3JR , Scotland.
Vladimir LarionovDevelopmental Therapeutics Branch , National Cancer Institute, NIH , Bethesda , Maryland 20892 , United States.
National Cancer Institute · USKazusa DNA Research Institute · JPWellcome Centre for Cell Biology · GBJosep Carreras Leukaemia Research Institute · ES

Funding

Study of hereditary prostate cancer and human artificial chromosomesZIABC010413 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LARIONOV, VLADIMIR · 2009 to 2025
$31.5M
Biotechnology and Biological Sciences Research Council BB/M018040/1Medical Research CouncilWellcome Trust 107022
6 · The paper itself

Abstract

Since their description in the late 1990s, Human Artificial Chromosomes (HACs) bearing functional kinetochores have been considered as promising systems for gene delivery and expression. More recently a HAC assembled from a synthetic alphoid DNA array has been exploited in studies of centromeric chromatin and in assessing the impact of different epigenetic modifications on kinetochore structure and function in human cells. This HAC was termed the alphoid

Indexed as

AnimalsCentromereCentromere Protein BChromosomal InstabilityChromosomes, Artificial, HumanGene Transfer TechniquesHistonesHumansNeoplasmsCENPB protein, humanCentromere Protein BHistoneschromosome instabilityCINgene delivery vectorHAChuman artificial chromosomekinetochore

Identifiers

PMID30075081
PMCPMC6154217
OpenAlexW2885100656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.